MarketFriction

One Global Service Provider Ltd

NSE ONEGLOBAL · BSE 514330 · Healthcare Service Provider
₹525.40 -0.47%
NSE close2026-10-01
52 week range494.00 - 580.00
Market cap₹1,046 Cr.
P/E14.1
Price band 5% Delivery 65.1%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1215241419335588135141134103
Expenses111319111629417510911211084
Operating Profit125235151326292419
OPM %8%14%22%17%16%14%26%15%19%21%18%19%
Other Income000000000000
Interest000000000000
Depreciation000000000000
Profit before tax125235151326292419
Tax %25%25%26%25%25%27%25%25%25%25%25%25%
Net Profit114223111020221814
EPS in Rs0.972.055.592.483.204.9015.4813.8210.1311.089.317.32
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales00020461863147498513
Expenses00020151653122405414
Operating Profit-0-000-021210259399
OPM %73%14%68%23%9%15%17%19%19%
Other Income000000000111
Interest00000000-0000
Depreciation000000000111
Profit before tax-0-000-021110259399
Tax %0%0%0%0%0%0%-3%-1%25%26%25%
Net Profit-0-000-02117187074
EPS in Rs-0.11-0.130.270.38-0.423.281.481.9410.0126.0035.5637.84
Dividend Payout %0%0%0%0%0%0%0%0%10%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%167%202%162%
Compounded Profit Growth97%97%269%181%
Stock Price CAGR55%93%121%91%
Return on Equity53%56%59%65%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital77777777772020
Reserves-5-5-5-5-4-5-2-10752122
Borrowings000100000000
Other Liabilities0002101251734113
Total Liabilities333543681332106254
Fixed Assets000000111122
CWIP333333333300
Investments000000000000
Other Assets00021035928104252
Total Assets333543681332106254
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-0-0-0-00-0110114-11
Cash from Investing Activity000000-1-1-0-0-0-0
Cash from Financing Activity0000-000000-1-0
Net Cash Flow-00-0-0000-0-0114-11
Free Cash Flow-0-0-0-00-0-0-0-0114-11
CFO/OP90%162%111%-32%141%6%45%38%8%12%67%12%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days3651490242164152134159
Inventory Days0000000
Days Payable91
Cash Conversion Cycle365149024216415213468
Working Capital Days4213714913576575977
ROCE %-4%-3%-3%6%9%-11%60%18%20%85%56%87%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters29.51%29.51%29.51%29.51%29.51%29.51%15.05%15.05%66.24%68.38%68.40%68.40%
FIIs0.00%0.00%0.00%7.97%15.26%14.98%14.98%14.98%5.44%5.45%5.44%7.72%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%
Public70.49%70.50%70.49%62.52%55.24%55.53%69.97%69.98%28.31%26.16%26.14%23.87%
No. of Shareholders3,5503,6234,3734,2585,2416,3836,2566,3746,4138,0168,4619,204

Fundamentals

Market Cap₹ 1,046 Cr.
Current Price₹ 534
Stock P/E14.1
Book Value₹ 72.3
ROCE87.0 %
ROE65.3 %
Dividend Yield0.19 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)162%
Compounded Profit Growth (TTM)181%
Standalone figures.
Valuation
Market capRs 1,027 Cr
Enterprise valueRs 1,011 Cr
P/E (TTM)13.89x
Price to book7.27x
Price to sales2.00x
EV / EBITDA10.17x
EV / EBIT10.24x
EV / sales1.97x
Earnings yield7.20%
P/E, 3-year average20.08x
P/B, 3-year average6.83x
P/E, 5-year average20.63x
P/B, 5-year average5.66x
Profitability
Operating margin (excl. other income)18.64%
Operating margin (incl. other income)18.77%
EBITDA margin19.39%
Pre-tax margin19.25%
Net profit margin14.42%
Net margin, latest quarter13.91%
ROE65.27%
ROCE87.03%
ROA38.55%
ROE, 3-year average57.91%
ROCE, 3-year average76.34%
ROA, 3-year average32.39%
ROE, 5-year average42.83%
ROCE, 5-year average53.39%
ROA, 5-year average24.82%
ROIC (approx.)58.88%
Tax rate25.11%
Other income / net worth0.45%
Growth
Sales growth (latest year)239.06%
Profit growth (latest year)276.29%
Sales CAGR, 3 years201.82%
Sales CAGR, 5 years167.02%
Profit CAGR, 3 years269.29%
Profit CAGR, 5 years97.21%
Sales growth QoQ-23.20%
Profit growth QoQ-21.39%
Sales growth YoY (latest quarter)17.01%
Profit growth YoY (latest quarter)45.62%
Per share
EPS (TTM)Rs 37.83
EPS (latest year)Rs 35.56
EPS (latest quarter)Rs 7.32
EPS, 3-year averageRs 18.34
EPS, 5-year averageRs 11.69
Book value per shareRs 72.27
Sales per shareRs 262.41
Cash flow per shareRs -5.59
Free cash flow per shareRs -5.63
Dividend per share, 3-year averageRs 1.00
Dividend per share, 5-year averageRs 1.00
Dividends
Dividend payout, 3-year average9.99%
Dividend payout, 5-year average9.99%
Efficiency
Asset turnover1.96x
Fixed asset turnover278.31x
Inventory turnover38912.00x
Inventory days0 days
Debtor days159 days
Debtors turnover2.30x
Creditor days91 days
Cash conversion cycle68 days
Working capital days77 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 16 Cr
Net debtRs -16 Cr
Debt to equity0.00x
Net debt / EBITDA-0.16x
Interest coverage9872.00x
Owners' fund to total sources55.55%
Debt to assets0.01%
Cash flow
Cash from Operating Activity (latest year)Rs -11 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -11 Cr
Free cash flow (latest year)Rs -11 Cr
FCFE (approx.: FCF + change in debt)Rs -11 Cr
Cash from ops / profit, 5 years0.05x
Statement figures
Net sales (TTM)Rs 513 Cr
Net sales (latest year)Rs 498 Cr
Sales (latest quarter)Rs 103 Cr
Operating profit excl. other income (latest year)Rs 93 Cr
Operating profit (latest quarter)Rs 19 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 99 Cr
PBDT (TTM)Rs 99 Cr
Profit before tax (TTM)Rs 99 Cr
Tax (latest year)Rs 23 Cr
Net profit (TTM)Rs 74 Cr
Net profit (latest year)Rs 70 Cr
Net profit (latest quarter)Rs 14 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 389 Cr
Total expenditure (latest year)Rs 405 Cr
Total income (latest year)Rs 499 Cr
Share capitalRs 20 Cr
ReservesRs 122 Cr
Shareholders' fundsRs 141 Cr
Total assetsRs 254 Cr
Net blockRs 2 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 217 Cr
InventoryRs 0 Cr
Other liabilitiesRs 113 Cr
Shares outstanding (crore)1.95
Ownership
Promoter holding68.40% (+53.35 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 13.9 is at the 2th percentile of its own 7.3-year range (median 42.3, low 8.6, high 139.5).
P/B 7.27 is at the 40th percentile (median 8.31).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodONEGLOBALNifty 50Difference
1 week-1.0%-2.8% +1.7 pts
1 month+2.2%-6.8% +9.0 pts
3 years+956.1%+14.2% +941.9 pts
5 years+2650.8%+27.9% +2622.9 pts

Red flags

F-score 5 of 8
explainWeak cash conversion Cash from operations was 5% of net profit over the last 3 years
explainHigh accruals Profit exceeded operating cash by 32% of total assets in 2026
explainReceivables outrunning sales Receivables grew 301% vs sales +239% in 2026
explainShare dilution Share count up 175% in a year, 175% in three
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹103 Cr +17.0% vs Jun 2025. Net profit ₹14 Cr +40.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
Star Imaging and Path Lab Ltd1316.8026.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-09-22Dividend - Re 1 Per Share
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of One Global Service Provider Ltd?

One Global Service Provider Ltd (ONEGLOBAL) has a market capitalisation of Rs 1,046 Cr. at the 2026-10-01 close.

What is the P/E ratio of One Global Service Provider Ltd?

One Global Service Provider Ltd trades at a P/E of 14.1 on trailing twelve-month profit, at the 2026-10-01 close.

What were One Global Service Provider Ltd's latest quarterly results?

In the Jun 2026 quarter, One Global Service Provider Ltd sales was Rs 103 Cr (+17.0% vs Jun 2025) and net profit was Rs 14 Cr.

What is the 52-week high and low of One Global Service Provider Ltd?

The 52-week high is Rs 580.00 and the 52-week low is Rs 494.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03